SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $460,016 | -44.1% | 193,284 | +12.5% | 0.00% | – |
Q2 2023 | $822,960 | +164.3% | 171,808 | +212.8% | 0.00% | – |
Q1 2023 | $311,413 | +4306.6% | 54,923 | +4252.1% | 0.00% | – |
Q4 2022 | $7,067 | -72.8% | 1,262 | -69.8% | 0.00% | – |
Q3 2022 | $26,000 | +116.7% | 4,174 | +27.4% | 0.00% | – |
Q2 2022 | $12,000 | -82.9% | 3,276 | -66.2% | 0.00% | – |
Q1 2022 | $70,000 | -74.5% | 9,696 | -70.7% | 0.00% | – |
Q4 2021 | $275,000 | -28.4% | 33,037 | -40.1% | 0.00% | – |
Q3 2021 | $384,000 | -44.6% | 55,159 | +89.8% | 0.00% | – |
Q2 2021 | $693,000 | -44.6% | 29,061 | -52.2% | 0.00% | – |
Q1 2021 | $1,251,000 | -56.9% | 60,738 | -48.8% | 0.00% | -100.0% |
Q4 2020 | $2,905,000 | -24.3% | 118,568 | -12.5% | 0.00% | 0.0% |
Q3 2020 | $3,837,000 | +735.9% | 135,578 | +40.8% | 0.00% | – |
Q2 2020 | $459,000 | +57.2% | 96,278 | +17.6% | 0.00% | – |
Q1 2020 | $292,000 | +15.9% | 81,836 | +12.1% | 0.00% | – |
Q4 2019 | $252,000 | -5.3% | 73,025 | +10.1% | 0.00% | – |
Q3 2019 | $266,000 | +109.4% | 66,333 | +68.1% | 0.00% | – |
Q2 2019 | $127,000 | -8.6% | 39,466 | +94.3% | 0.00% | – |
Q1 2019 | $139,000 | +202.2% | 20,313 | +98.9% | 0.00% | – |
Q4 2018 | $46,000 | -41.8% | 10,211 | -1.9% | 0.00% | – |
Q3 2018 | $79,000 | -6.0% | 10,410 | +7.7% | 0.00% | – |
Q2 2018 | $84,000 | -61.6% | 9,666 | -67.6% | 0.00% | – |
Q1 2018 | $219,000 | -26.0% | 29,821 | +2.2% | 0.00% | – |
Q4 2017 | $296,000 | +31.0% | 29,183 | +107.2% | 0.00% | – |
Q3 2017 | $226,000 | +20.2% | 14,086 | -15.6% | 0.00% | – |
Q2 2017 | $188,000 | -45.3% | 16,684 | -45.3% | 0.00% | – |
Q1 2017 | $344,000 | -64.3% | 30,518 | -68.6% | 0.00% | – |
Q4 2016 | $963,000 | +1184.0% | 97,232 | +1485.1% | 0.00% | – |
Q3 2016 | $75,000 | -59.9% | 6,134 | -4.7% | 0.00% | – |
Q2 2016 | $187,000 | +45.0% | 6,434 | +32.9% | 0.00% | – |
Q1 2016 | $129,000 | -15.7% | 4,842 | +10.9% | 0.00% | – |
Q4 2015 | $153,000 | +15200.0% | 4,366 | +12374.3% | 0.00% | – |
Q3 2015 | $1,000 | – | 35 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |